Explore Pharmaceutical Industry
We balance an internal portfolio of drug discovery projects with fully integrated research collaborations on targets with pharmaceutical and biotechnology companies, and academic partners. Our shared-risk approach ensures a high level of engagement from our scientists and rewards success. Recently disclosed research collaborations include those with Servier, Daiichi Sankyo, Lundbeck, PhoreMost and Asahi Kasei Pharma, and we seek additional partnerships.
We also, have an extensive pipeline of partnered new chemical entities in pre-clinical and clinical development with Celgene, Corvus, CTI BioPharma, Cumulus Oncology, Servier and Verona Pharma, and we explore additional licensing opportunities for our currently unpartnered drug candidates.